Data as of Sep 12, 2026. Both funds on the fields they both publish, from the same sources.
CGBL vs XLV: how they differ
CGBL and XLV hold 5% of their weight in the same names, and XLV returned more over the year.
Capital Group Core Balanced ETF and State Street(R) Health Care Select Sector SPDR(R) ETF.
What they hold in common
By the books each fund has filed, CGBL and XLV hold 5% of their money in the same securities at the same weight.
| Holding | CGBL | XLV |
|---|---|---|
| Vertex Pharmaceuticals Inc | 1.20% | 2.20% |
| Gilead Sciences Inc | 0.74% | 2.74% |
| Eli Lilly & Co | 0.73% | 16.56% |
| UnitedHealth Group Inc | 0.63% | 6.59% |
| Amgen Inc | 0.54% | 3.41% |
| CVS Health Corp | 0.48% | 2.30% |
| Thermo Fisher Scientific Inc | 0.31% | 3.25% |
| Only in CGBL | Only in XLV |
|---|---|
| Capital Group Core Plus Income ETF 23.22% | Johnson & Johnson 10.67% |
| Capital Group Core Bond ETF 15.60% | AbbVie Inc 7.76% |
| Broadcom Inc 4.57% | Merck & Co Inc 5.54% |
| Taiwan Semiconductor Manufacturing Co Lt 3.48% | Abbott Laboratories 2.76% |
| Alphabet Inc 2.78% | Intuitive Surgical Inc 2.46% |
| Micron Technology Inc 2.23% | Pfizer Inc 2.40% |
| Philip Morris International Inc 2.07% | Danaher Corp 2.10% |
| Apple Inc 2.00% | Bristol-Myers Squibb Co 2.05% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Jun 30, 2026.
| CGBL Capital Group Core Balanced ETF | XLV State Street(R) Health Care Select Sector SPDR(R) ETF | |
|---|---|---|
| Where it sits | Core index fund | Core index fund |
| Issuer | Capital | State Street |
| What it is | Core Balanced | Health care |
| Total return, 1 year | +9.9% | +20.4% |
| S&P 500 over the same days | +17.5% | +17.5% |
| Gap to the S&P 500 | −7.6 pts | +2.9 pts |
| Expense ratio | 0.33% | 0.08% |
| Already in the S&P 500 | 48.1% | 100.0% |
| Holdings | 77 | 59 |
CGBL in plain words
CGBL is an index equity fund tracking the Core Balanced. Over the year to Sep 11, 2026 it returned +9.9% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.33% a year. By its holdings filed for Jun 30, 2026, 48% of the fund by weight is stocks the S&P 500 also holds, across 77 positions, with the top ten at 59.2%.
XLV in plain words
XLV is an index equity fund tracking the Health care. Over the year to Sep 11, 2026 it returned +20.4% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.08% a year. By its holdings filed for Jun 30, 2026, 100% of the fund by weight is stocks the S&P 500 also holds, across 59 positions, with the top ten at 61.7%. It sat 5.9% below its high of Aug 19, 2026 on Sep 11, 2026.
Questions people ask
- Which returned more over the last year, CGBL or XLV?
- In the year to Sep 12, 2026, with distributions reinvested, CGBL returned +9.9% and XLV returned +20.4%, so XLV returned more. One year is one year; the longer windows are in the table.
- Which is cheaper, CGBL or XLV?
- CGBL charges 0.33% a year and XLV charges 0.08%, so XLV is cheaper. Fees come from each fund's prospectus.
- How much do CGBL and XLV overlap with the S&P 500?
- By their latest filed holdings, 48% of CGBL and 100% of XLV by weight is stocks the S&P 500 already holds. Between the two funds, 5% of their books are the same securities at the same weight.
Other comparisons
Where to next
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, CGBL against XLV, data as of Sep 12, 2026. https://etfiq.com/compare/any/CGBL-XLV Free to use with attribution; the underlying files are at Open data.
A comparison is not a recommendation. Standards and sources